Showing results (901-910 of 3,769) with videos related to

Sort By:
Pageof 377
Radiation Oncology (London, England)|November 24, 2022
Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient imagesSaman Moradi, Bijan Hashemi, Mohsen Bakhshandeh, et al.
Radiation Oncology (London, England)|July 1, 2022
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systemsGiorgio Hamid Raza, Luca Capone, Paolo Tini, et al.
Radiation Oncology (London, England)|December 9, 2022
Rectal retractor in prostate radiotherapy: pros and consHamed Ghaffari, Arezoo Mehrabian
Radiation Oncology (London, England)|October 14, 2020
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancerDavid Krug, Christine Köder, Matthias F Häfner, et al.
Radiation Oncology (London, England)|October 22, 2020
Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysisKaikai Zhao, Youjiao Si, Liangchao Sun, et al.
Radiation Oncology (London, England)|February 1, 2020
Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patientsSara Moore, Bonnie Leung, Jonn Wu, et al.
Radiation Oncology (London, England)|August 29, 2020
Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA projectMagdalena Fundowicz, Artur Aguiar, Carla Lopes de Castro, et al.
Radiation Oncology (London, England)|July 16, 2021
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitisWeronika Maria Szejniuk, Martin Skovmos Nielsen, Zsuzsanna Takács-Szabó, et al.
Radiation Oncology (London, England)|July 14, 2021
Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burdenJoanne D Stockton, Louise Tee, Celina Whalley, et al.
Radiation Oncology (London, England)|June 11, 2021
Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysisLipin Liu, Qiuzi Zhong, Ting Zhao, et al.
Pageof 377